Clonal myelodysplastic cells present in apheresis product before transplantation

Leukemia. 1998 Sep;12(9):1497-9. doi: 10.1038/sj.leu.2401116.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carmustine / administration & dosage
  • Chromosome Aberrations / genetics*
  • Chromosomes, Human, Pair 15 / genetics
  • Chromosomes, Human, Pair 7 / genetics
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Cytarabine / administration & dosage
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Stem Cell Mobilization* / adverse effects
  • Hematopoietic Stem Cells*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / therapy
  • Lymphoma, Follicular / genetics*
  • Lymphoma, Follicular / therapy
  • Melphalan / administration & dosage
  • Middle Aged
  • Podophyllotoxin / administration & dosage
  • Retrospective Studies

Substances

  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Cyclophosphamide
  • Podophyllotoxin
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM protocol